IS7707A
Sustained release formulations comprising lamotrigine
Abstract
A sustained release formulation of lamotrigine or a pharmaceutically acceptable derivative thereof and methods of treatment and uses thereof.
Term
Term ended
Projected expiry passed 23 February 2025, 1.6 years ago.
- Priority
- Filed and published
- Projected expiry
- Today
53 members in 31 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 0217492 | United Kingdom | A | |
| 0217492 | United Kingdom | A | |
| 0217493 | United Kingdom | A | |
| 0217493 | United Kingdom | A | |
| 0313801 | United Kingdom | A | |
| 0313801 | United Kingdom | A | |
| 0308368 | European Patent Office (EPO) | W | |
| 0308368 | European Patent Office (EPO) | W | |
| GB02174936A | – | – | – |
| GB20020017492 | – | – | – |
| GB20020017493 | – | – | – |
| GB20030013801 | – | – | – |
| PCTEP2003008368 | – | – | – |
| WO2003EP08368 | – | – | – |
Members53
| Document | Office | Kind | |
|---|---|---|---|
| GB0217492D0 | United Kingdom | D0 | |
| GB0217493D0 | United Kingdom | D0 | |
| GB0313801D0 | United Kingdom | D0 | |
| CA2493301A1 | Canada | A1 | |
| WO2004012741A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003260336A1 | Australia | A1 | |
| US2004192690A1 | United States of America | A1 | |
| TW200418484A | Taiwan Province of China | A | |
| US2005032799A1 | United States of America | A1 | |
| NO20050948L | Norway | L | |
| IS7707AThis record | Iceland | A | |
| KR20050026054A | Republic of Korea | A | |
| AR040709A1 | Argentina | A1 | |
| EP1524981A1 | European Patent Office (EPO) | A1 | |
| MXPA05001243A | Mexico | A | |
| BR0313148A | Brazil | A | |
| MA27509A1 | Morocco | A1 | |
| CN1681509A | China | A | |
| RU2005105353A | Russian Federation | A | |
| PL374982A1 | Poland | A1 | |
| JP2005538113A | Japan | A | |
| IL166424A0 | Israel | A0 | |
| HK1077003A1 | Hong Kong, China | A1 | |
| ZA200500518B | South Africa | B | |
| CO5680405A2 | Colombia | A2 | |
| NZ537885A | New Zealand | A | |
| CN100363007C | China | C | |
| RU2325163C2 | Russian Federation | C2 | |
| AU2003260336C1 | Australia | C1 | |
| CN101229169A | China | A | |
| KR100882707B1 | Republic of Korea | B1 | |
| EP1524981B1 | European Patent Office (EPO) | B1 | |
| AT424827T | Austria | T | |
| ATE424827T1 | Austria | T1 | |
| DE60326590D1 | Germany | D1 | |
| RU2007143372A | Russian Federation | A | |
| PT1524981E | Portugal | E | |
| DK1524981T3 | Denmark | T3 | |
| ES2323268T3 | Spain | T3 | |
| SI1524981T1 | Slovenia | T1 | |
| MY141049A | Malaysia | A | |
| IS2681B | Iceland | B | |
| IL166424A | Israel | A | |
| JP2011057683A | Japan | A | |
| TWI342213B | Taiwan Province of China | B | |
| JP4744142B2 | Japan | B2 | |
| CN101229169B | China | B | |
| PL213565B1 | Poland | B1 | |
| NO334221B1 | Norway | B1 | |
| US8637512B2 | United States of America | B2 | |
| CY1109119T1 | Cyprus | T1 | |
| BRPI0313148B1 | Brazil | B1 | |
| BRPI0313148B8 | Brazil | B8 |
Numbers
- Publication, DOCDB
- 7707
- Publication, EPODOC
- IS7707
- Application
- 7707
- Application, DOCDB
- 7707
- Application, EPODOC
- IS20050007707
Titles2
- Icelandic
- Efnablöndur með tafða losun sem innihalda lamótrígín
- English
- Delayed-release preparations containing lamotrigine
Classification
- CPC, 13
- A61K31/53
- A61K9/2031
- A61K9/2054
- A61K9/2846
- A61K9/2866
- A61P25/00
- A61P25/04
- A61P25/08
- A61P25/18
- A61P25/28
- A61P37/00
- A61P7/10
- A61K9/20
- IPC, 15
- A61K31 53
- A61K9 20
- A61K9 22
- A61K9 28
- A61K9 30
- A61K9 48
- A61K47 12
- A61K47 34
- A61K47 38
- A61P7 10
- A61P25 00
- A61P25 04
- A61P25 08
- A61P25 18
- A61P25 28